Clinical Trial Update: Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating quercetin in patients with XIAP deficiency; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xiap Deficiency

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: XIAP Deficiency | Phase 1 | Status: RECRUITING